Novel Test Distinguishes Benign From Malignant Lesions in NF1 Novel Test Distinguishes Benign From Malignant Lesions in NF1

As well as distinguishing between benign precursor lesions and malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1, it can also be used to track response to treatment.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news